🇮🇳

Index Intelligence

· daily

BSE Bankex Banking Sector Regulatory Filings — May 14, 2026

BANKEX constituents show robust FY26 performance with Bank of Baroda and Canara Bank reporting record profits (BoB Rs. 20,021 Cr +YoY, Canara Rs. 19,187 Cr +12.69% YoY), strong advances growth (BoB 16.2% YoY, Canara 15.3% YoY), and deposit expansion (both ~12% YoY), alongside improving asset quality (GNPA down 37bps/110bps YoY to 1.89%/1.84%). However, Q4 profitability dipped at Canara due to one-off losses (net profit -Rs. 2,300 Cr QoQ) and rose credit costs at BoB (0.76% vs. 0.44%). Management provided FY27 guidance with BoB upsizing to 12-14% loans/10-12% deposits and Canara reaffirming conservative 11-12% advances at NIM 2.5-2.6%. Yes Bank faces a significant pledge creation over 8.49% shares by Verventa Holdings, signaling potential liquidity pressures, while neutral analyst meets for Yes Bank and Federal Bank indicate routine engagement. Mixed sentiments dominate high-materiality filings, with portfolio-level themes of growth resilience but provisioning headwinds from ECL norms. Implications include bullish credit expansion momentum tempered by Q4 volatility and regulatory provisioning risks.

1 high priority 4 medium 5 total filings
· daily

BSE Pharma Sector Regulatory Filings — May 14, 2026

In the BSE PHARMA sector, Q4 FY26 earnings highlight robust growth led by Lupin with 32% YoY revenue and 68% EBITDA surge, contrasting Biocon's milder 10% revenue growth ex-one-time items, signaling US and biosimilars as key drivers amid mixed India performance. Aggregate revenue growth across reporting firms averages ~21% YoY in Q4 (Lupin 32%, Biocon 10%), with EBITDA margins expanding sharply (Lupin gross to 75% from 61.7% YoY, Biocon generics +300 bps QoQ). Aurobindo schedules earnings on May 22, 2026, kicking off catalyst season, while Sun Pharma's promoter reclassification of 1.80% shares to public could enhance free float. Sector themes include outperformance in US sales (Lupin +40% YoY) and biosimilars (Biocon +12% YoY), but CRDMO flatness at Biocon and modest India FY growth (Lupin +7.1%) flag domestic pressures. No capital allocation or insider trades noted beyond reclass, with forward pipelines (Lupin 50+ US launches) building multi-year alpha. Overall, mixed sentiment prevails, but Lupin emerges as top performer, warranting overweight amid earnings momentum.

4 medium 4 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — May 14, 2026

The three filings from BSE Realty constituents reveal heightened investor engagement post-Q4 FY26 earnings, with The Phoenix Mills conducting a physical roadshow in Chennai on May 14, 2026, and scheduling a virtual interaction on May 20, 2026, while DLF released its Q4 FY26 and FY26 earnings webcast recording on the same day. All disclosures carry neutral sentiment, with DLF's materiality at 5/10 outperforming Phoenix's 3/10, signaling relatively stronger focus on earnings transparency. No period-over-period financial trends, insider trading activity, forward-looking guidance changes, capital allocation details, or M&A transactions were disclosed across filings, limiting quantitative portfolio-level insights. Common theme is proactive communication compliance under SEBI Reg 30, potentially building investor confidence amid realty sector recovery. Upcoming virtual meet on May 20 presents a near-term catalyst for potential operational updates. No margin compressions, revenue growth rates, or ROE trends identifiable due to absence of financial metrics. Actionable implication: Review DLF recording immediately and monitor Phoenix event for sector guidance.

3 medium 3 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — May 13, 2026

Across 21 filings from BSE Sensex 30 companies dated May 13, 2026, Bharti Airtel dominates with 14 disclosures revealing FY26 consolidated revenue growth of 16-22% YoY to ₹2,10,973 Cr alongside EBITDA expansion of 15-29% YoY, but PAT declines of 10-38% YoY due to higher depreciation (up 16% YoY), exceptional items (₹34 Bn FY), and taxes, highlighting telecom sector top-line strength amid bottom-line pressures. Strategic positives include Airtel's cash-less share swap for 16.31% Airtel Africa stake (EPS accretive, at 9.5% premium issuance), steady ₹24/share final dividend recommendation, and customer base expansion to 666 Mn (+12.8% YoY) with ARPU at ₹257 (+5% YoY). L&T secured significant PT&D orders (₹1-2.5K Cr), while others like UltraTech flag IEPF deadlines (July 15, 2026) and neutral governance updates prevail. Portfolio-level trends show revenue acceleration (e.g., Airtel India +7.7-13% YoY) but margin stability at ~58% EBITDA offset by PAT volatility; capex remains high (Airtel ₹16K Cr Q4). Upcoming catalysts cluster around May 18-28 earnings calls and investor meets, signaling potential volatility in telecom, pharma, and auto. Overall mixed sentiment (9/21 mixed/neutral) underscores growth resilience but profitability risks, favoring tactical plays on catalysts.

5 high priority 16 medium 21 total filings
· daily

BSE Metal Sector Regulatory Filings — May 13, 2026

The three filings from BSE METAL constituents reveal a focus on investor engagement and capital management amid neutral sentiment across the board, with no major period-over-period financial trends disclosed but upcoming catalysts poised to provide guidance updates. Jindal Steel's analyst meet and Hindalco's Novelis earnings call signal heightened transparency, potentially revealing YoY trends in steel/aluminum volumes (sector avg +8% YoY inferred from prior briefs) and margins (avg -50 bps QoQ). Adani Enterprises' rights issue reminders highlight ongoing capital allocation with 24-day payment window, risking forfeiture but advancing full paid-up status (ISIN INE423A01024). Portfolio-level patterns show 3/3 filings event-driven with materiality avg 4.7/10, emphasizing short-term catalysts over operational metrics. No insider trading or M&A noted, but scheduled events cluster May 18-19, 2026, could flag guidance changes amid metal price volatility. Implications: Watch for outperformance in Hindalco (sub sales $17.1B FY25 baseline) vs Adani's dilution risks.

1 high priority 2 medium 3 total filings
· daily

BSE Auto Sector Regulatory Filings — May 13, 2026

In the India BSE AUTO sector, Q4 and FY26 results dominate 19 filings, revealing robust revenue growth across key players (Tube Investments +8.4-16.4% YoY, Tata Motors +11-22% YoY standalone, TVS Motor +30.4% YoY) but sharp PAT declines in Tube (-36.2% FY26) and Tata (-23-24%) due to exceptional items and absence of prior gains, contrasting TVS's +37.2% PAT surge on 24.1% volume growth. EBITDA margins expanded at Tata (+120-130 bps) and TVS (+60 bps normalized), signaling operational strength amid sector headwinds. Capital allocation favors shareholders with Tata's ₹4 final dividend (200% FV) and TVS ₹12 interim, while forward catalysts include Tata's Iveco acquisition closure by Q2 FY27 and June 29 AGM. Mixed sentiment prevails (Tube/Tata mixed, TVS positive), with portfolio-level trends showing revenue acceleration QoQ in Q4 but profitability pressure from one-offs; TVS emerges as clear outperformer vs peers. Administrative updates (Exide RTA change, KMP shifts) are neutral, but investor meets signal engagement.

7 high priority 12 medium 19 total filings
· daily

BSE FMCG Sector Regulatory Filings — May 13, 2026

FMCG sector filings reveal a mix of governance updates, investor engagements, and one detailed Q4 FY26 performance report, with Godrej Consumer Products leading on materiality amid strong domestic growth offset by international investments. Godrej reported consolidated 11% INR revenue growth on 6% UVG, 10% EBITDA growth at 21.7% margins, and 10% PAT growth, while standalone India showed 10% sales growth on 8% UVG with 18% EBITDA expansion to 24.7% margins; however, Personal Care lagged at 3% growth and international profits weakened due to doubled media spends despite 20-26% topline gains. Other filings highlight upcoming catalysts like Marico's independent director appointment via postal ballot (e-voting May 15-June 13, 2026), Emami's investor conference on May 28, 2026, and S&S Power Switchgears' audited results board meeting on May 22, 2026. No insider trading or capital allocation changes noted across filings, but Godrej's revenue presentation tweak optically boosts margins without EBITDA/PAT impact. Portfolio-level trends show resilient domestic UVG (6-8%) contrasting mixed international execution, signaling sector focus on India amid investment cycles. Key implication: Watch late-May catalysts for guidance on FY27 growth and margin sustainability.

4 medium 4 total filings
· daily

BSE IT Technology Sector Regulatory Filings — May 13, 2026

In the India BSE IT stream, the sole filing from Wipro Limited details the allotment of 2,669,612 equity shares (1,489,948 under ADS RSU 2004, 502,241 under RSU 2007, and 677,423 under ESOP/PSU/RSU 2024) on May 13, 2026, pursuant to ESOP exercises, reflecting ongoing employee incentive programs amid neutral sentiment (materiality 4/10). No period-over-period comparisons were highlighted, but this routine ESOP activity signals sustained employee participation and stock price appreciation above strike levels, with minimal dilution impact given Wipro's ~10.4 billion shares outstanding (<0.03% dilution). Absent forward-looking statements or insider trading data, the event underscores stable capital allocation towards talent retention in a competitive IT sector. No portfolio-level trends emerge from this single filing, but it aligns with BSE IT firms' historical ESOP reliance for motivation without major financial strain. Market implications are limited, suggesting neutral positioning for Wipro shares short-term, with focus shifting to broader Q1 FY27 earnings for growth confirmation.

1 medium 1 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — May 13, 2026

Across four BSE BANKEX constituents, disclosures center on neutral investor relations activities, with three filings highlighting recent or upcoming analyst/investor meetings and one on dividend tax compliance, reflecting proactive engagement amid stable sector conditions. No new period-over-period financial trends (YoY/QoQ revenue, margins, or ratios) were disclosed in these low-materiality (2-3/10) updates, suggesting no immediate shifts in operational metrics like NIM, ROE, or deposit growth. Key theme: Dense international and domestic IR calendar (London, Singapore, Hong Kong, Mumbai) from Federal Bank, AU Small Finance Bank, and Yes Bank, signaling management conviction in communicating strategies to global investors. HDFC Bank's dividend tax notice implies near-term capital allocation via payouts, consistent with sector dividend trends. Portfolio-level pattern: 75% of new filings (3/4) focus on investor meets, a bullish IR push post-Q1 2026 with no bearish insider activity or guidance changes reported. Implications: Time-sensitive catalysts ahead, but absence of enriched financial updates keeps near-term volatility low.

4 medium 4 total filings
· daily

BSE Pharma Sector Regulatory Filings — May 13, 2026

Across 17 filings from BSE Pharma constituents, FY26 results reveal muted revenue growth averaging ~2% YoY for GSK Pharma (up 2% to ₹3822 Cr) and Cipla (up 2.2% to ₹28,163 Cr), with Q4 showing QoQ declines (GSK -4%, Cipla -2.8% YoY/-7.6% QoQ). Profit trends diverge sharply: GSK up 12% YoY to ₹1036 Cr aided by ₹20.6 Cr exceptional credit and 2% lower expenses, while Cipla plunged 26.7% YoY to ₹3862 Cr due to ₹276 Cr exceptional loss and impairments. Capital allocation remains shareholder-friendly with GSK hiking final dividend to Rs.57/share (up from Rs.54 total FY25), Cipla at Rs.13/share, and Zydus proposing buyback on May 19 plus acquiring Assertio for $166M to bolster US oncology footprint (ROLEDON +13.6% YoY). Mixed sentiment dominates (9/17 filings), with neutral on earnings events; no insider trades noted but positive on Zydus M&A. Key catalysts cluster in May-June: earnings (Zydus/Sun May 19/22), dividend records (GSK May 29, Cipla June 5), AGMs (Cipla June 25, GSK June 30). Sector implies steady returns amid flat growth, watch for Q4 weakness signaling demand softness.

17 medium 17 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — May 13, 2026

The India BSE REALTY stream filings on May 13, 2026, are dominated by four high-materiality disclosures from DLF Limited announcing audited Q4 and FY2026 standalone/consolidated results with unmodified auditor opinions and a recommended ₹8 per share dividend (400% on ₹2 face value), overshadowed by mixed sentiment due to material litigation uncertainties including a ₹630cr CCI penalty under Supreme Court appeal, stayed High Court orders on IT SEZ/IT Park projects, and pending SEBI restrictions. The Phoenix Mills Limited's single neutral, low-materiality filing details a non-deal investor roadshow in Chennai, signaling routine IR activity without financial updates. No explicit period-over-period financial trends (YoY/QoQ revenue, margins) are detailed across filings, but minor immaterial restatements for prior periods (Q3 FY26, Q4 FY25, FY25) due to amalgamation show net profits/losses of ₹0.72cr to ₹5.73cr, indicating stable but unremarkable adjustments. Portfolio-level patterns highlight earnings season onset with strong capital returns via dividends amid regulatory overhang, contrasting Phoenix's low-engagement event. Key implications include potential short-term dividend yield boost for DLF versus litigation-driven volatility discount; sector themes point to legal risks tempering realty optimism.

5 medium 5 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — May 12, 2026

Across 11 filings from BSE Sensex 30 constituents and related firms, dominant themes include heightened investor engagement in banking (ICICI, Axis, SBI) with multiple Asia-Pacific conferences scheduled May 18-20, 2026, signaling strong institutional interest amid no reported period declines. Positive strategic expansions shine in Adani Ports' subsea contract and 200-vessel fleet target by FY31 (₹6,000cr marine revenue, ₹13,000cr capex) and TCS' AI commerce partnership with Rezolve Ai, with no YoY/QoQ deteriorations noted. Capital allocation trends favor debt raises: Mahindra Finance (₹875cr NCDs at 7.90%), Bajaj Finance (₹2,892cr NCDs at 7.77-8.00%), and SBI (up to $2B foreign bonds FY27), reflecting robust funding access and financial health (positive sentiment, materiality 7-8/10). Neutral governance updates like Satin Creditcare's debenture fundraising meeting (May 15) and ICICI ESOP allotment (887k shares) show steady operations. Portfolio-level, finance sector dominates (7/11 filings) with bullish capital trends vs neutral investor comms; no insider selling or margin compressions reported, implying stable conviction. Actionable: Monitor May 18-20 conferences for guidance updates; Adani/TCS as growth outliers.

11 medium 11 total filings
· daily

BSE Metal Sector Regulatory Filings — May 12, 2026

The two filings from BSE METAL constituents reveal routine regulatory compliance and an upcoming investor event with neutral sentiment across the board, reflecting steady but unremarkable sector activity on May 12, 2026. Adani Enterprises' IEPF notice for FY 2018-19 unclaimed shares highlights ongoing governance efforts with no financial impact (materiality 3/10), while SAIL's analyst meet for Q4 FY26 results discussion (materiality 4/10) serves as a key forward-looking catalyst. No period-over-period financial trends, insider trading activity, capital allocation changes, or M&A details are disclosed in these non-financial updates, limiting quantitative insights but underscoring compliance focus amid metals sector volatility. SAIL shows relatively higher materiality, suggesting potential for guidance updates; Adani's older FY18-19 reference indicates resolved legacy issues. Portfolio-level, neutral disclosures imply stable management priorities without red flags, but investors should monitor SAIL's concall for Q4 trends in volumes, margins, or steel prices. Overall, low materiality signals no immediate sector disruption, with emphasis on scheduled events for alpha.

2 medium 2 total filings
· daily

BSE Auto Sector Regulatory Filings — May 12, 2026

BSE AUTO sector filings highlight robust FY26 performance at Bajaj Auto with record revenues of INR58,000 crores (+implied strong YoY growth), EBITDA margins at 20.5%, and Q4 volumes up 24% YoY to 13.7 lakh units, driven by exports (+25% YoY), premium bikes (+43%), and EVs, though tempered by Nigeria underutilization and April demand softness. Samvardhana Motherson signals upcoming FY26 results and potential debt fundraising on May 20, 2026, amid neutral sentiment. Mahindra & Mahindra Financial Services completed a INR875 crore NCD allotment at 7.90% coupon, reflecting positive funding access. Portfolio-level trends show export-led growth and EV momentum as key themes, with 1/3 filings reporting record metrics and another financing strength, but mixed signals from demand headwinds. Critical implications include monitoring Q4/FY26 earnings catalysts and supply chain risks, positioning select auto names for outperformance amid sector recovery.

3 medium 3 total filings
· daily

BSE FMCG Sector Regulatory Filings — May 12, 2026

The India BSE FMCG stream reveals mixed execution in FY26 Q4, with leaders like Radico Khaitan, Tata Consumer, Marico, and Dabur posting revenue growth of 18%, strong volumes, multi-year highs, and 7.3% YoY respectively, but offset by segment degrowths, international disruptions, and supply issues; EBITDA margins expanded notably (Radico 19% highest ever, Tata +100 bps to 14.6%). Premium/luxury segments shone (Radico 28% volume growth, Marico Value Added Hair Oils 20%, Dabur HPC 17%), signaling premiumization theme, while regular segments lagged (Radico 4% modest IMFL). Forward guidance is optimistic (Radico 25% luxury value/20% Prestige volume FY27, Dabur Q1 acceleration), with capital returns via Tata's 1000% dividend (Rs10/share) and Radico's 20% PAT payout policy. Procedural filings from Satin Creditcare and Godrej add limited alpha but flag fundraising (Satin May 15) and prior earnings access. Sector shows resilient domestic growth amid volatility, positioning premium plays for outperformance; investors should watch H1 FY27 debt-free milestones and Q1 acceleration. Overall, 4/8 high-materiality filings bullish on growth/margins, implying selective upside in a 10-20% YoY revenue expansion portfolio trend.

8 medium 8 total filings
· daily

BSE IT Technology Sector Regulatory Filings — May 12, 2026

In the India BSE IT stream, NIIT Learning Systems dominates with three filings detailing FY26 audited results showing robust 18% YoY revenue growth to ₹19,519.84 Mn driven by Q4 22% surge and acquisitions (MST Group EUR 22.37 Mn, NIIT USA), but mixed profitability with PAT up 9% YoY to ₹2,477.23 Mn offset by 4% YoY PBT decline before exceptionals due to 10% higher employee costs and 51% jump in professional fees. TCS announced a bullish strategic AI partnership with Rezolve Ai on May 12, 2026, entering agentic AI commerce via brainpowa™ platform, leveraging its global network. Portfolio-level trends highlight inorganic growth via M&A as a key driver (2 acquisitions in NIIT), but margin pressures from integration costs and labor impacts; dividend recommendation at ₹5.25/share (FV ₹2) signals capital return stability. An analyst call audio for NIIT provides post-results insights. Overall, sector themes point to AI innovation upside in TCS contrasting NIIT's acquisition-fueled top-line beat with bottom-line caution, creating tactical opportunities ahead of trading window reopen on May 15, 2026.

4 medium 4 total filings
· daily

BSE Bankex Banking Sector Regulatory Filings — May 12, 2026

BSE BANKEX constituents show heightened investor engagement with clustered analyst/investor meets May 18-20, 2026, including ICICI Bank, Axis Bank, and SBI at Citi Pan-Asia (Singapore), Motilal Oswal, Macquarie, and Jefferies events, signaling proactive IR amid FY26 close. PNB disclosed robust FY26 results with gross business +10.7% YoY to ₹29.7L cr, advances +12.7% YoY to ₹12.59L cr (15% ex-IBPC), deposits +9.2% YoY, Q4 net profit +14.4% YoY to ₹5,225 cr, and superior asset quality (GNPA -100 bps to 2.95%, NNPA to 0.29%, PCR 97.14%>96% guidance), though NIM compressed to 2.47% and ROA dipped to 0.89% from 0.97% due to tax hit. SBI approved examining $2B USD fund raise in FY26-27 via bonds, positive for growth funding. ICICI allotted 887k ESOP shares, supporting employee alignment; Federal Bank held multiple one-on-one meets. Portfolio trends: Broad growth in business/advances (PNB lead), asset quality strengthening, but NIM/CASA pressures evident in PNB; low insider activity, no M&A/dividends. Implications: Near-term catalysts from roadshows could drive updates on NIM recovery/guidance; watch for relative outperformance in private banks vs PSUs.

8 medium 8 total filings
· daily

BSE Pharma Sector Regulatory Filings — May 12, 2026

In the India BSE PHARMA stream, 11 filings highlight earnings season kickoff with mixed FY26 results from Dr. Reddy's Laboratories (revenue +3% YoY to ₹335,933M but profit -26% YoY to ₹42,466M due to 108% higher impairments at ₹3,519M) and Pfizer (revenue +10.5% YoY to ₹2,519.65 Cr but net profit -5.9% YoY from exceptional loss switch). Sector shows modest revenue growth (avg +6-7% YoY across reporters) but profit declines averaging -16% YoY from one-offs like impairments, shelf adjustments (-₹4,530M at Dr. Reddy's), and cost rises (SG&A +14% YoY). Capital allocation remains shareholder-friendly with dividends announced (Dr. Reddy's ₹8/share, record July 10; Pfizer ₹75/share or 750%, record July 17). Governance positives at Max Healthcare (91% approval for director re-appointment) contrast upcoming catalysts like Aurobindo's May 21 board for FY26 results and Torrent's May 22 investor call. Portfolio-level theme: Profit volatility from non-operational hits masks underlying generics growth, signaling short-term pressure but potential rebound on normalized costs. Implications: Rotate to outperformers like Pfizer on superior revenue trajectory; monitor Q4 weakness (Dr. Reddy's -12% YoY revenue).

11 medium 11 total filings
· daily

BSE Realty Real Estate Sector Regulatory Filings — May 12, 2026

The India BSE REALTY stream saw a very quiet session with two neutral sentiment filings focused on scheduled corporate events rather than financial disclosures. Prestige Estates Projects (materiality 8/10) announced a critical board meeting on May 21, 2026, for FY26 audited results (standalone/consolidated for quarter/year ended Mar 31, 2026), final dividend recommendation, and NCD issuance consideration, alongside an investor call on May 22, 2026, for results and outlook discussion. Brigade Enterprises (materiality 3/10) disclosed upcoming analyst/investor meets: virtual one-on-one with Equirus Capital on May 13, 2026, and physical Mumbai meet with ICICI Securities on June 9, 2026. No period-over-period comparisons (YoY/QoQ revenue, margins, etc.), insider trading activity, M&A details, or financial ratios were reported in these filings. Trading window closure at Prestige (Apr 1 to May 23, 2026) signals standard pre-earnings caution with no insider transactions noted. Overarching theme: Early catalyst buildup in realty sector ahead of Q4/FY26 disclosures, with Prestige offering higher actionability via dividend potential and debt plans amid neutral sentiment across both.

2 medium 2 total filings
· daily

BSE Sensex 30 Stocks Regulatory Filings — May 11, 2026

Across the 10 filings from BSE Sensex 30 constituents and related entities, the dominant theme is the onset of Q4/FY26 earnings season, with multiple board meetings scheduled for results approvals (Sun Pharma Advanced on May 18, Sun Pharma on May 22), signaling imminent financial disclosures amid trading window closures. Satin Creditcare Network stands out with robust FY26 performance, including 19.8% YoY revenue growth to ₹2,82,243.68 L, 39.5% YoY PAT surge to ₹30,208.07 L, and Q4 PAT exploding 333% YoY to ₹13,694.81 L, alongside 21.2% asset expansion to ₹13,19,627.91 L, highlighting NBFC strength in lending. Governance and leadership updates prevail in IT (HCL Tech independent director addition, Infosys promoter reclassification), banking (SBI director nomination withdrawal), and infra (Adani Ports CEO transition), mostly neutral but indicative of board refresh. No widespread insider trading or M&A activity noted, with limited capital allocation signals except Sun Pharma's upcoming dividend recommendation. Portfolio-level, positive sentiment isolated to Satin (materiality 9/10), while neutrals dominate; watch for earnings catalysts to drive Sensex volatility. Adjournment of Maruti Suzuki's CCI hearing to May 25 adds minor regulatory overhang.

10 medium 10 total filings